Europa: Intraartikuläre Injektion für osteoartikuläre Infiltrationen – Marktgröße und Prognose (2021–2031), Trend- und Wachstumschancenanalyse-Abdeckung: Nach Typ [Typ 1 Kollagen (polymerisiert, hydrolysiert und Atelokollagen) und Hyaluronsäure], Endbenutzer (Krankenhäuser, orthopädische Kliniken und andere) und Land

BMIRE00030877 | Pages: 90 | Medical Device | Oct 2024 | Status: Published

Der europäische Markt für intraartikuläre Injektionen zur osteoartikulären Infiltration soll von 97,43 Millionen US-Dollar im Jahr 2023 auf 157,08 Millionen US-Dollar im Jahr 2031 wachsen; für den Zeitraum 2023–2031 wird eine durchschnittliche jährliche Wachstumsrate von 6,2 % prognostiziert.

Intraartikuläre Injektionen gegen Osteoarthritis sind ein medizinisches Verfahren, bei dem Medikamente direkt in ein von Osteoarthritis betroffenes Gelenk injiziert werden. Dieser Ansatz soll Schmerzen lindern und die Gelenkfunktion verbessern. Das zunehmende Bewusstsein von medizinischem Fachpersonal und Patienten für die Vorteile dieser Injektionen sowie steigende Investitionen in die Gesundheitsinfrastruktur und Innovation erleichtern einen verbesserten Zugang zu diesen Behandlungen. Die zunehmende Prävalenz von Osteoarthritis und Fortschritte bei Injektionstechniken sind bemerkenswerte Faktoren, die zur Vergrößerung des europäischen Marktes für intraartikuläre Injektionen für osteoartikuläre Infiltrationen beitragen. Die mit intraartikulären Injektionen verbundenen Nebenwirkungen hemmen jedoch das Wachstum des europäischen Marktes für intraartikuläre Injektionen für osteoartikuläre Infiltrationen.

Intraartikuläre Injektionen gehören zu den innovativen und aufstrebenden Behandlungsfeldern für osteoartikuläre Infiltrationen. Hersteller nehmen an verschiedenen klinischen Studien teil, um die Sicherheit, Wirksamkeit und Zuverlässigkeit innovativer Medikamente sicherzustellen. So leitete das schwedische Unternehmen Synartro im Mai 2024 eine Kapitalerhöhung zwischen 3,73 und 7,36 Millionen US-Dollar ein, um eine klinische Studie des Osteoarthritis-Kandidaten SYN321 durchzuführen. Es befindet sich in der letzten Phase, um einen EU-Zuschuss von 2,78 Millionen US-Dollar zu erhalten. Darüber hinaus erhielt das Unternehmen im April 2023 von der schwedischen Arzneimittelbehörde und der schwedischen Ethikkommission die Genehmigung, mit der ersten klinischen Studie der Phase 1/2a am Menschen des Prüfmedikamentenkandidaten SYN321 zu beginnen. Auch andere Marktteilnehmer in den Regionen führen klinische Studien für intraartikuläre Injektionen durch, die zur Entwicklung innovativer Produkte führen können. So hat beispielsweise das deutsche Unternehmen Grünenthal im August 2022 den ersten Patienten in sein globales klinisches Phase-III-Programm für Resiniferatoxin (RTX) aufgenommen. Grünenthal hat drei Studien an rund 200 Standorten in Europa, den USA, Lateinamerika, Südafrika und Japan durchgeführt, um die Sicherheit und Wirksamkeit intraartikulärer Injektionen von RTX bei Erwachsenen zu untersuchen. Die in den Studien beobachteten Ergebnisse konzentrieren sich hauptsächlich auf eine Verbesserung der körperlichen Funktion und des Schmerzwerts im Osteoarthritis-Index der Western Ontario and McMaster Universities (WOMAC) vom Ausgangswert bis zur 52. Woche. Nach Abschluss des Phase-III-Programms soll die Marktzulassung für RTX in Europa, den USA und Japan erfolgen. Das Unternehmen beabsichtigt, im Jahr 2024 einen Antrag auf Zulassung eines neuen Arzneimittels einzureichen, was auf eine mögliche Markteinführung von RTX im Jahr 2025 hindeutet. Daher wird erwartet, dass die zunehmende Zahl klinischer Studien die Entwicklung innovativer Produkte in der Region fördert, was wiederum zum Wachstum des europäischen Marktes für intraartikuläre Injektionen für osteoartikuläre Infiltrationen in den kommenden Jahren beitragen wird.

Typbasierte Erkenntnisse

Basierend auf dem Typ ist der europäische Markt für intraartikuläre Injektionen für osteoartikuläre Infiltrationen in Kollagen Typ 1 und Hyaluronsäure segmentiert. Das Hyaluronsäuresegment hielt 2023 den größten Marktanteil für intraartikuläre Injektionen für osteoartikuläre Infiltrationen in Europa. Hyaluronsäure-Injektionen werden zur Behandlung von Knieschmerzen bei Patienten eingesetzt, bei denen andere Behandlungsmöglichkeiten nicht ansprachen. Jüngste Fortschritte in der Hyaluronsäure-Injektionstherapie haben die Wachstumskurve deutlich erweitert. Ein starker Fokus auf die Entwicklung und Einführung neuartiger Produkte auf dem Markt dürfte das Wachstum des Segments unterstützen und so zum Marktwachstum beitragen.

Die Centers for Disease Control and Prevention, die Weltgesundheitsorganisation und das National Center for Biotechnology Information gehören zu den primären und sekundären Quellen, die bei der Erstellung des europäischen Marktberichts für intraartikuläre Injektionen für osteoartikuläre Infiltrationen herangezogen werden.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Information on why collagen injections are better than HA injections

4.4 Pricing Analysis

5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics

5.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Prevalence of Osteoarthritis

5.2.2 Advancements in Injection Techniques

5.3 Market Restraints

5.3.1 Side Effects Associated with Intra-Articular Injections

5.4 Market Opportunities

5.4.1 Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations

5.5 Future Trends

5.5.1 Increasing Number of Clinical Trials

5.6 Impact of Drivers and Restraints:

6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis

6.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031

6.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis

7. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by Type

7.1 Type 1 Collagen

7.1.1 Overview

7.1.2 Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Hyaluronic Acid

7.2.1 Overview

7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by End User

8.1 Hospitals

8.1.1 Overview

8.1.2 Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Orthopedic Clinics

8.2.1 Overview

8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Country Analysis

9.1 Europe

9.1.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries

9.1.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country

9.1.2.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country

9.1.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.2.1 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.2.3 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.3.1 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.3.2 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.3.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.4 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.4.1 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.4.2 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.4.3 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.5 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.5.1 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.5.2 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.5.3 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.6 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.6.1 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.6.2 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.6.3 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.7 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.7.1 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.7.2 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.7.3 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

9.1.2.8 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.8.1 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type

9.1.2.8.2 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen

9.1.2.8.3 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

10. Industry Landscape

10.1 Overview

10.2 Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Bioventus Inc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 SEIKAGAKU CORPORATION

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Maxigen Biotech Inc.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 ?stem Medical Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Sanofi SA

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Ferring Pharmaceuticals

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Fidia Pharma USA Inc.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Biotech Healthcare Group

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Bioteck S.p.A.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 I+MED

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation

Table 2. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Table 3. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Country

Table 7. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 8. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 9. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 10. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 11. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 12. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 13. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 14. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 17. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 18. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 19. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 20. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 21. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 22. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 23. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 24. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 25. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 26. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen

Table 27. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 28. Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market

Table 29. Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market

Table 30. Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market

List of Figures

Figure 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031

Figure 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by Type, 2023 and 2031

Figure 6. Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by End User, 2023 and 2031

Figure 9. Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)

Figure 13. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20. Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe intra-articular injection for osteoarticular infiltrations market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe intra-articular injection for osteoarticular infiltrations market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3550

$2485

Site License

$4550

$3185

Enterprise License

$5550

$3885

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription